View Author
plasma mutation sample patient concentration study solution townes-brocks syndrome syndrome nerve anomaly netherland method −80 ◦ c qc samples protein erasmu myelin stability 2–8 ◦ c 50 l hypomyelinating neuropathy levetiracetam neuropathy pharmacokinetic volume water townes-brock neonate matrix phase methanol family p.arg 276x mutation matrix effects ucb 17025 seizure precipitation analysis precision effect department phenotype chromatogr column assay rotterdam 1000 l sall 1 gene sall 1 fi nal protein precipitation inaccuracy calibration 1.50 hospital level condition report father plasma samples ion suppression deviation 7 days 0.5 result pharmacokinetic study infusion fication table phase solution erasmus university chromatography children p.arg response nerve conduction studies suppression composition 2–8
3 Most Recent Publications
|
Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry
(Article)
Blonk, M.I. Nagel, B.C. van der Smit, L.S. Mathot, R.A.A. |
2010-03-01
|
|
Obstructive apneas and severe dysphagia in a girl with Townes-Brocks syndrome and atypical feet involvement
(Article)
Bever, Y. van Gischler, S.J. Hoeve, L.J. Smit, L.S. Nauta, J. Dooijes, D. |
2009-11-01
|
|
Congenital hypomyelinating neuropathy, a long term follow-up study in an affected family
(Article)
Smit, L.S. Roofthooft, D. Ruissen, F. van Baas, F. Doorn, P.A. van |
2008-01-01
|